Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol glycan anchor biosynthesis class Q pseudogene 1 (PIGQP1) is annotated in gene databases as a pseudogene within the PIG gene family, which consists of genes involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. However, as a pseudogene, PIGQP1 is generally considered non-functional: it does not encode a functional protein product and is not described as involved in any known molecular, physiological, or disease process. There are no scientific reports describing it as a therapeutic target or as playing a role in drug mechanisms, signaling, cellular biology, or pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol glycan anchor biosynthesis class Q pseudogene 1 (PIGQP1).